Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

3.19
Delayed Data
As of Apr 29
 -0.02 / -0.62%
Today’s Change
2.38
Today|||52-Week Range
8.04
-24.41%
Year-to-Date
No recent news for Array Biopharma Inc.

Today’s Trading

Previous close3.21
Today’s open3.20
Day’s range3.15 - 3.26
Volume1,667,850
Average volume (3 months)2,088,294
Market cap$460.1M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-922.45%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+23.36%
P/E ratio1,107.6
Price/Sales19.68
Price/Book10.69

Competitors

 Today’s
change
Today’s
% change
NLNKNewLink Genetics Cor...+0.33+2.08%
CTMXCytomX Therapeutics ...+0.11+0.86%
LOXOLoxo Oncology Inc-0.45-1.91%
SCMPSucampo Pharmaceutic...-0.14-1.28%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$51.9M
Annual profit (last year)$9.4M
Net profit margin18.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers

Search for Jobs